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Abstract The Ussing chamber system is named after the Danish zoologist Hans 
Ussing, who invented the device in the 1950s to measure the short-circuit current as 
an indicator of net ion transport taking place across frog skin (Ussing and Zerahn, 
Acta Physiol Scand 23:110–127, 1951). Ussing chambers are increasingly being 
used to measure ion transport in native tissue, like gut mucosa, and in a monolayer 
of cells grown on permeable supports. However, the Ussing chamber system is, to 
date, not often applied for the investigation of the impact of food bioactives (pro-
teins, sugars, lipids) on health.
An Ussing system is generally comprised of a chamber and a perfusion system, 
and if needed, an amplifier and data acquisition system. The heart of the system lies 
in the chamber with the other components performing supporting roles. The classic 
chamber design is still in wide use today. However, several newer designs are now 
available that optimize for convenience and for diffusion- or electrophysiology- 
based measurements. A well designed Ussing chamber supports an epithelia mem-
brane or cell monolayer in such a way that each side of the membrane is isolated and 
faces a separate chamber-half. The chambers are then filled with a physiologically 
relevant solution, such as Ringer’s solution. This configuration allows the researcher 
to make unique chemical and electrical adjustments to either side of the membrane 
with complete control. The Ussing chamber technique has its strengths and limita-
tions, which will be explained in more detail in this chapter.
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24.1  The Ussing Chamber
A commercially available ‘classic’ Ussing chamber system (Fig. 24.1) is machined 
from solid acrylic into two halves and has vertical and horizontal ports in each half 
for connection to the circulation system and for making electrical connections. The 
face of one chamber-half is imbedded with sharp stainless-steel pins which mate 
with corresponding holes in the other chamber-half face. These pins allow punctur-
ing and positioning of an epithelium membrane within the chamber. Each chamber- 
half also has a separate air/gas inlet to drive the circulation system. Gas, commonly 
a 95 % O2/5 % CO2 mixture, is forced under low pressure into these inlets and 
allows contact with the buffer solution. The rising bubbles drive circulation and 
oxygenate the buffer. Each chamber-half also has an inlet or outlet port for access to 
the water jacket. Water at the desired temperature is pumped through the jacket and 
allowing thermoregulation of the perfusion solutions. Each chamber is supplied 
with 2 Ag-AgCl pellet electrodes (for voltage) and 2 Ag wire electrodes (for current). 
Electrodes are connected into the chamber by means of an agar salt bridge.
One of the major limitations of the classic Ussing chamber model is that it does 
not allow simultaneous preparation and analyses of a large set of segments of epi-
thelial tissues thereby having a relatively low throughput. The original Ussing 
chamber system incorporates the intestinal tissue segments in a vertical position, 
whereas other systems also allow horizontal placement (e.g. TNO’s InTESTine™
system or Warner Instruments’ NaviCyte™). This horizontal setup can be used for
transport or toxicology studies using cells or tissue exposed to liquids and semi- 
solid compounds, such as digested food samples, while the basolateral surface 
remains exposed to the medium.
Fig. 24.1 Schematic representation of a small piece of intestinal epithelial tissue mounted in the 
Ussing chamber
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Further development of the Ussing chamber system has led to various multichannel 
systems capable of supporting up to 24 independent chambers, all operating in 
parallel. TNO recently developed a medium throughput system (InTESTine™) in
which up to 96 ex vivo intestinal tissue segments can be used per system per day to 
investigate intestinal absorption (Westerhout et al. 2014).
Food compounds can be transported across the intestinal barrier by different 
transport mechanisms (Fig. 24.2). The transport route and velocity of absorption of 
these compounds are influenced by different factors that are related to physiological 
factors of the tissue (e.g. composition and thickness of the mucus layer, disease state 
or membrane permeability, intestinal pH, concentration bile acids, composition of 
pancreatic juice, surface area, enzyme activity, lipid and protein content of the 
enterocyte membrane and the amount of Peyer’s patches in the tissue), physico-
chemical factors of the compound (e.g. water solubility, molecular weight, aggrega-
tion state, charge, H-bonding capacity, and hydrophobicity) and formulation factors 
(e.g. food matrix) (Deferme et al. 2008).
In general compounds are transported via one of the following mechanisms:
 (1) Paracellular (e.g. small hydrophilic and polar compounds)
 (2) Transcellular
 – passive transport (lipophilic compounds)
 – endocytosis (e.g. proteins and small nucleotides)
 – carrier mediated transport (e.g. glucose and amino acids)
Fig. 24.2 Different transport routes across the intestinal wall (Reitsma et al. 2014, copyright 
Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission)
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 (3) Cell mediated transport
In contrast to single cell-culture models, such as the epithelial Caco-2 cell model,
intestinal epithelium consists of absorptive enterocytes and other cells such as gob-
let cells, endocrine cells, and M cells, with the mucus secreting goblet cells repre-
senting the second most frequent cell type, ranging from 10 % in the small intestine 
and 24 % in the distal colon (Madara and Trier 1987). The transport of food com-
pounds across the intestinal barrier can also be facilitated by the other cell types 
present in the lamina propria (Fig. 24.3), including M cells, Peyer’s patches, den-
dritic cells and macrophages.
As the Ussing chamber technique uses intestinal tissue segments, they still con-
tain the morphological and physiological features of the intestine, including inter-
play of many complex processes, such as interaction between the multicellular 
environment (Rozehnal et al. 2012). Using ex vivo intestinal tissue segments gives 
a better representation of the complex in vivo morphology (multicellular conglom-
eration, presence of the mucus layer) and thereby a better representation of the vari-
ous possible processes involved in the in vivo situation. Furthermore, ex vivo 
intestinal tissue segments from the different regions of the small and large intestine 
allow the investigation of regional absorption and immune responses, which is not 
possible when using single cell-culture models.
The major limitation of using ex vivo intestinal tissue segments is the limited 
availability of (healthy) human tissue. Therefore, animal tissue is often used. Porcine 
intestinal tissue could possibly be used as alternative based on its high similarity 
with that from humans (Patterson et al. 2008; Walters et al. 2011; Groenen et al. 
2012). When using human tissue, often a small segment of non-diseased biopsy is 
Fig. 24.3 The intestine at a cellular level (Reitsma et al. 2014, copyright Wiley-VCH Verlag
GmbH & Co. KGaA. Reproduced with permission)
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used, which could be more-or-less influenced by the adjacent diseased tissue. 
However, besides the effects of the possible side effects of diseased tissue and/or 
historic drug treatment, the inter-individual variability among humans or any other 
non in-bred animal model also in a healthy stage is high, making it difficult to 
directly compare results.
Another major limitation of using ex vivo intestinal tissue segments is the limited 
viability of the tissue. Previous studies by Haslam et al. (2011), Rozehnal et al. 
(2012) and Sjöberg et al. (2013) have shown that the intestinal tissue remains viable 
only for up to 150 min (on average 120 min), which is long enough to study absorp-
tion and/or secretion of satiety hormones. For the investigation of the impact of food 
bioactives on other health effects 2 h may be too short for any clear response, such 
as release of cytokines, reversible disruption of tight junctions, extensive metabo-
lism. However, changes in mRNA levels within 2 h should be measurable by using 
reverse transcription polymerase chain reactions (RT-PCR).
24.2  General Protocol
Human intestinal tissue segments are often obtained via biopsies or by surgical 
resection, whereas intestinal tissue segments from animals are often obtained from 
section of sacrificed animals. Collect the intestine, directly after opening the 
abdominal cavity, in a cold Krebs’ Ringer Bicarbonate buffer (pH 7.4), supple-
mented with 25 mM HEPES (KRB/HEPES), which is bubbled with a O2/CO2 
(95/5 %) gas mixture, prior to use to prevent ischemia (e.g. during transport). The 
intestine can be divided in different segments; duodenum can be found directly after 
the stomach and is approx. 20 cm long, followed by the jejunum (approx. 1.0 m), 
ileum (approx. 1.6 m) and after the cecum you will find the colon (approx. 1.1 m) 
(DeSesso et al. 2001).
Upon arrival in the laboratory, flush and rinse the intestinal tissue segments care-
fully with ice cold physiologically relevant buffer, such as KRB/HEPES buffer, to
remove luminal debris and put in a beaker with KRB/HEPES on ice. The tissue
segments are then opened longitudinally next to the juncture to the peritoneum and 
the serosa and muscle layers are removed (stripping) while the tissue is submerged 
in chilled and oxygenated KRB/HEPES buffer. Removal of muscle layers is either
performed using scissors keeping the feather scissor at an angle towards the mus-
cles, or using a pair of curved tweezers to gently strip off the muscle layers while 
holding the rim of the tissue segment with a Kocher. After the muscle layer is gen-
tly removed, the tissue is cut clean from fat, connective tissue and parts of the sub- 
mucosa to reach the blood vessel level. Depending on the system, intestinal tissue 
segments with a surface area of 0.1–1.8 cm2 are prepared using for instance a 
punch. Keep the tissue and segments in cold buffer during the whole procedure.
Stripped intestinal segment is then mounted in the Ussing chamber system 
(Fig. 24.4). Since epithelial tissue is polarized, it contains an apical (mucosal) and 
basolateral  (serosal) side, so pay attention on how to mount the tissue in the system. 
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Both chamber halves are then filled with ice cold physiologically relevant buffer,
such as KRB/Hepes buffer. The basolateral KRB/HEPES buffer is sometimes
supplemented with 0.1 % bovine serum albumin (BSA) to enhance intestinal trans-
port. The solution is then oxygenated (95 % O2:5 % CO2), circulated, and warmed 
to 37 °C. Once at 37 °C, carefully flush the mucus layer from the segments and 
replace the apical buffer by fresh, pre-warmed buffer containing the compound of 
interest, to investigate the permeability. In most cases compounds are labelled
radioactively (e.g. 14C) or with a fluorescent label. During the permeability studies 
small (100 μl) samples are taken over time from the basolateral and apical compart-
ment for up to 150 min. After 150 min, the viability of the tissue and the integrity of 
the intestinal barrier starts to decrease (Sjöberg et al. 2013). If desired, the basolat-
eral and apical buffer can be supplemented with fresh, pre-warmed, blank buffer, to 
complement for the samples taken. Usually, an apparent permeability value (Papp 







* ,0  
(24.1)
Here, dQ/dt (in disintegrations per minute (dpm)/s or mg/s) indicates the rate of 
transport of the compound from the apical side to the basolateral side over time 
when the rate of transport is linear (usually between T = 60 and T = 120 min), SA is 
the surface area of the exposure area (cm2) and CApi,0 is the initial donor concentra-
tion of the compound (concentration at apical side at T = 0 in dpm/ml or mg/ml).
To study the absorption of compounds, the presence of an unstirred water layer 
upon the enterocytes should be prevented by continuous moving of the incubation 
buffers, either by gassing of the media (Ussing system) or placement of the complete 
system on a rocker platform (InTESTine™ system, Westerhout et al. 2014). Care 
must also be taken to prevent nonspecific binding of the test compound,  evaporation 
of the media during incubation, cross-contamination of the test compound to other 
Fig. 24.4 (a) Photograph of obtaining a small segment from stripped porcine intestinal tissue by 
using a hollow punch. (b) The smaller segments are then mounted in the InTESTine™ system
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chambers (especially in case of gassing of the incubation media). The reusable 
Ussing system therefore requires thorough cleaning and fine adjustment of the 
gassing rate prior to performing experiments. The InTESTine™ system inserts
are generated from disposable glass material, which reduces nonspecific binding 
of the compound of interest and risk of contamination of the mounted device. 
Furthermore, the set-up and horizontal mounting enables the InTESTine™ system
to be incubated in a carbogenated, humidified incubator at 37 °C on a rocker plat-
form thereby reducing the unstirred water layer, evaporation and possible foaming 
(Westerhout et al. 2014).
24.3  Monitoring Viability
Previous studies by Haslam et al. (2011), Rozehnal et al. (2012) and Sjöberg et al. 
(2013) have used the potential difference (>4mV), short-circuit current (>100 μA/cm2), 
trans epithelial electrical resistance (TEER; >20 Ω cm2) for continuous monitoring 
of the viability. Low resistance indicates tissue leakage. Due to the set-up of the 
Ussing chamber system, these measurements can be performed for each experiment. 
Other markers that can be studied in parallel to a typical transport study include the 
intestinal metabolism of testosterone and midazolam, by measuring the presence of 
metabolites apically, basolaterally and intracellularly by means of, for instance, 
High Pressure Liquid Chromatography (HPLC) (Sjöberg et al. 2013). Transport via 
the paracellular pathway can be assessed by measuring the permeability of Lucifer 
yellow (Papp value <6 × 10−6 cm/s) (Rozehnal et al. 2012) leakage of fluorescein 
isothiocyanate dextran to the basolateral side (FD4; <0.5 %) (Westerhout et al. 
2014), or the linearity of transport of atenolol (R2 > 0.995 with at least 3 datapoints) 
(Haslam et al. 2011). Values higher than the ones mentioned above, indicate leakage
of the intestinal tissue. Ideally, one would monitor multiple parameters to evaluate
the viability and integrity of the intestinal mucosa in parallel to the transport of the 
compound of interest, but in some cases the compound of interest has the same 
properties as the marker compounds (e.g. when using fluorescently labeled or radio-
labeled compounds).
24.4  Use of Digested Food Samples
While we have shown that undiluted digested food samples (including bile, pancre-
atic enzymes and/or food components), obtained by using TNO’s dynamic 
computer- controlled in vitro gastrointestinal model of the stomach and small intes-
tine (TIM-1, Minekus et al. 1995) can be applied directly onto intestinal tissue seg-
ments (Westerhout et al. 2014), it must be noted that the digested food samples can 
also be presented in a different formulation. Care should be taken that the levels of 
alcohol and DMSO are below 1 % and other conditions, such as bile salt concentra-
tion, osmolarity and pH, are in concordance towhat has been presented byBergström
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et al. (2014). In general, bile salt concentrations should be between 1.4 and 24 mM,
the osmolarity should be between 137 and 416 mOsm and the pH should be between 
5.4 and 7.8.
24.5  Readout of the Ussing Chamber System
Since the Ussing chamber system is not often applied for the investigation of the 
impact of food bioactives (proteins, sugars, lipids) on health it is difficult to identify 
typical readout parameters. To date, the Ussing chamber has been applied to inves-
tigate the general transport of proteins, sugars and lipids across intestinal tissue 
(Table 24.1). The readout for these types of studies is the percentage of the applied 
dose that can be detected in the basolateral compartment intact using for instance 
radiolabel counting (e.g. 3H, 125I, 14C), HPLC coupled to a mass spectrometer or UV
Table 24.1 Different absorption studies using intestinal tissue segments of different species 
mounted in the Ussing chamber system
References Species Protein Sugar Lipid
Food- 
related Analysis
Ducroc et al. 
(1983)
Rabbit HRP No Enzymatic activity, 
3H-radioactive 
labeling
Gabler (2009) Pig Glucose Yes Potential difference
Hardin et al. 
(1999)


















Pig HRP No Enzymatic activity
Larsen et al. 
(2001)












Rabbit Cholesterol Yes Merckotest




Glucose Yes 14C-radioactive 
labeling





labeling and HPLC 
gel filtration
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detector or enzymatic activity. While horseradish peroxidase (HRP) and BSA are
not food-related, at least it shows that the Ussing chamber technique can be applied 
to investigate the transport of proteins across intestinal tissue. At TNO we are cur-
rently investigating the possibility to use porcine intestinal tissue segments for 
studying the transport of different allergens across intestinal tissue. Furthermore, 
we also use porcine intestinal tissue segments to monitor cytokine release at mRNA 
levels, since cytokine release at protein level is limited due to viability issue’s men-
tioned before.
24.6  General Advantages, Disadvantages and Limitations 
of the Ussing Chamber System
The Ussing chamber system is, to date, not often applied for the investigation of the 
impact of food bioactives (proteins, sugars, lipids) on health. This indicates that still 
a lot of research can be done in this field. The general advantages and disadvantages 
of the Ussing chamber system are summarized in Table 24.2.
Open Access This chapter is distributed under the terms of the Creative Commons Attribution 
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